Financials
- Market Capitalization 3.75 B
- Employee 975
- Founded 2007
- CEO N/A
- Website www.iovance.com
- Headquarter Delaware, United States
- FIGI BBG000FTLBV7
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
0.03
Fiyat/satışlar oranı
0.01
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1538 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 33.84 USD | +0.27% | -9.66% | +66.78% | +267.83% | 3.77 B USD | ||
| 1540 | DNLI Denali Therapeutics Inc. - Common Stock | 23.26 USD | -2.10% | -6.70% | +1.79% | +43.85% | 3.72 B USD | ||
| 1557 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.86 USD | -2.07% | -7.10% | +6.47% | +72.11% | 3.68 B USD | ||
| 1591 | VCYT Veracyte, Inc. - Common Stock | 43.45 USD | +0.60% | -1.34% | -6.28% | +17.75% | 3.49 B USD |